Sunday, June 16, 2024

GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line

Must read

The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022

More articles


Please enter your comment!
Please enter your name here

Latest article